Form 4 for VERU VERU INC.
Accepted 2024-05-17 00:00:00 ET · period of report 2024-05-15 · accession 0001042167-24-000039 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-05-17 | 2024-05-15+ | VERU | STEINER MITCHELL SHUSTER | Pres, CEO, Dir | S - Sale | $1.44 | -171.9K | 7.04M | -2% | -$247.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-17 | S | D | 28,066 | $1.32 | 7,012,892 | D | — | — | (F1) Dr. Steiner sold the shares referenced above to help address certain personal matters. The sold shares represent only 1.7% of Dr. Steiner's total beneficial ownership in the Company. After these sales, Dr. Steiner will beneficially own 9,686,180 shares, and will continue to be the Company's second largest shareholder. (F4) The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.3000 to $1.3450. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-05-15 | S | D | 84,021 | $1.50 | 7,100,746 | D | — | — | (F1) Dr. Steiner sold the shares referenced above to help address certain personal matters. The sold shares represent only 1.7% of Dr. Steiner's total beneficial ownership in the Company. After these sales, Dr. Steiner will beneficially own 9,686,180 shares, and will continue to be the Company's second largest shareholder. (F2) The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.4800 to $1.5200. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-05-16 | S | D | 59,788 | $1.41 | 7,040,958 | D | — | — | (F1) Dr. Steiner sold the shares referenced above to help address certain personal matters. The sold shares represent only 1.7% of Dr. Steiner's total beneficial ownership in the Company. After these sales, Dr. Steiner will beneficially own 9,686,180 shares, and will continue to be the Company's second largest shareholder. (F3) The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.3800 to $1.4650. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price. |